KORU Medical Systems, Inc.

KRMD is the ticker symbol for KORU Medical Systems, Inc., a publicly traded US company.

KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.

Key metrics include a return on equity of -4.8%, a debt-to-equity ratio of 0.69.

The company reports trailing twelve-month revenue of $11.76M and net loss of $807,078.

FINOTAUR aggregates real-time and fundamental data on KRMD to help traders and investors make informed decisions. Track KRMD in your trading journal alongside other positions for a unified view of your portfolio.